364 related articles for article (PubMed ID: 29572107)
1. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
[TBL] [Abstract][Full Text] [Related]
2. Effects of corneal nerve density on the response to treatment in dry eye disease.
Kheirkhah A; Dohlman TH; Amparo F; Arnoldner MA; Jamali A; Hamrah P; Dana R
Ophthalmology; 2015 Apr; 122(4):662-8. PubMed ID: 25542519
[TBL] [Abstract][Full Text] [Related]
3. A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease.
Kheirkhah A; Di Zazzo A; Satitpitakul V; Fernandez M; Magilavy D; Dana R
Cornea; 2017 Jul; 36(7):799-804. PubMed ID: 28445193
[TBL] [Abstract][Full Text] [Related]
4. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.
Sheppard JD; Donnenfeld ED; Holland EJ; Slonim CB; Solomon R; Solomon KD; McDonald MB; Perry HD; Lane SS; Pflugfelder SC; Samudre SS
Eye Contact Lens; 2014 Sep; 40(5):289-96. PubMed ID: 25083776
[TBL] [Abstract][Full Text] [Related]
5. Loteprednol Etabonate for the Treatment of Dry Eye Disease.
Beckman K; Katz J; Majmudar P; Rostov A
J Ocul Pharmacol Ther; 2020 Sep; 36(7):497-511. PubMed ID: 32391735
[TBL] [Abstract][Full Text] [Related]
6. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
[TBL] [Abstract][Full Text] [Related]
8. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
[TBL] [Abstract][Full Text] [Related]
9. Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.
Amparo F; Shikari H; Saboo U; Dana R
Ocul Surf; 2018 Jul; 16(3):377-381. PubMed ID: 29763694
[TBL] [Abstract][Full Text] [Related]
10. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
Ozen S; Ozer MA; Akdemir MO
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.
Safarzadeh M; Azizzadeh P; Akbarshahi P
J Optom; 2017; 10(4):258-264. PubMed ID: 27989693
[TBL] [Abstract][Full Text] [Related]
12. Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.
Saboo US; Amparo F; Abud TB; Schaumberg DA; Dana R
Ophthalmology; 2015 Aug; 122(8):1669-74. PubMed ID: 26001816
[TBL] [Abstract][Full Text] [Related]
13. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease.
Tawfik A; Pistilli M; Maguire MG; Chen Y; Yu Y; Greiner JV; Asbell PA; Ying GS;
Ophthalmic Epidemiol; 2024 Jun; 31(3):274-282. PubMed ID: 37592829
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.
Liew SH; Nichols KK; Klamerus KJ; Li JZ; Zhang M; Foulks GN
Ophthalmology; 2012 Jul; 119(7):1328-35. PubMed ID: 22525048
[TBL] [Abstract][Full Text] [Related]
16. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
[TBL] [Abstract][Full Text] [Related]
17. A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study.
Sheppard JD; Wirta DL; McLaurin E; Boehmer BE; Ciolino JB; Meides AS; Schlüter T; Ousler GW; Usner D; Krösser S
Cornea; 2021 Oct; 40(10):1290-1297. PubMed ID: 34481407
[TBL] [Abstract][Full Text] [Related]
18. A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.
Abud TB; Amparo F; Saboo US; Di Zazzo A; Dohlman TH; Ciolino JB; Hamrah P; Dana R
Ophthalmology; 2016 Jul; 123(7):1449-57. PubMed ID: 27086024
[TBL] [Abstract][Full Text] [Related]
19. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM
J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease.
Tauber J; Wirta DL; Sall K; Majmudar PA; Willen D; Krösser S;
Cornea; 2021 Sep; 40(9):1132-1140. PubMed ID: 33369937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]